scispace - formally typeset
P

Peter W. Jones

Researcher at Keele University

Publications -  327
Citations -  19716

Peter W. Jones is an academic researcher from Keele University. The author has contributed to research in topics: Population & Genotype. The author has an hindex of 76, co-authored 324 publications receiving 18761 citations. Previous affiliations of Peter W. Jones include University Hospital of Wales & University of Birmingham.

Papers
More filters
Journal ArticleDOI

Efficacy of progesterone and progestogens in management of premenstrual syndrome: Systematic review

TL;DR: There is inadequate evidence to justify the continued prescription of these agents for women having premenstrual syndrome, which may well not represent progesterone deficiency, according to a systematic review of randomized placebo-controlled trials.
Journal ArticleDOI

How should airways resistance be measured in young children: mask or mouthpiece?

TL;DR: The reproducibility and acceptability of airways resistance measurements using the interrupter technique (MicroRint) obtained using a mouthpiece were compared with those using a face mask, but there are significant clinical and statistical differences between the results obtained.
Journal ArticleDOI

Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival.

TL;DR: It is concluded that the association of GSTM1 null/GSTTl null with survival appears to be mediated through different mechanisms to p53 expression in ovarian cancer and in addition, may be a better predictor of outcome.
Journal ArticleDOI

Plasma protein levels in normal human fetuses: 13 to 41 weeks' gestation

TL;DR: The levels of alpha-fetoprotein, albumin, prealbumin, transthyretin, alpha-1-antitrypsin, transferrin, ceruloplasmin and total protein in the plasma of normal human fetuses and newborn babies were investigated in this paper.
Journal ArticleDOI

Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation.

TL;DR: Recursive partitioning was used to identify combinations of exposure parameters that distinguished 453 prostate cancers from 312 benign hypertrophy patients, and subgroups with a 13.0-fold increased risk of cancer were identified.